Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_733f9f206a30eb241a0e7ece400747f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45ab00e7e6be7eeefb30ffac21b44b2e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7406fafb8b895173fc4b4690a1ebede6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00e46b767e52e66199003478f922132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492e923fcbf14224bbb8eeed8c8c473f |
publicationDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019161550-A1 |
titleOfInvention |
Antibodies against mac-1 |
abstract |
The present invention provides an isolated monoclonal antibody or an antigen-binding portion thereof which n a) binds to Mac-1,n nb) specifically inhibits the interaction of CD40L with activated Mac-1 andn nc) does not induce integrin outside-in signaling. |
priorityDate |
2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |